Chiara Temperoni

692 total citations
9 papers, 491 citations indexed

About

Chiara Temperoni is a scholar working on Infectious Diseases, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Chiara Temperoni has authored 9 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Molecular Medicine and 3 papers in Applied Microbiology and Biotechnology. Recurrent topics in Chiara Temperoni's work include Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and COVID-19 and Mental Health (2 papers). Chiara Temperoni is often cited by papers focused on Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and COVID-19 and Mental Health (2 papers). Chiara Temperoni collaborates with scholars based in Italy and United States. Chiara Temperoni's co-authors include Matteo Bassetti, Maria Merelli, Francesco Barchiesi, Zeno Pasquini, Roberto Montalti, Benedetta Canovari, Paolo Gaibani, Linda Bussini, Pierluigi Viale and Michele Bartoletti and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Arthritis Research & Therapy and BMC Infectious Diseases.

In The Last Decade

Chiara Temperoni

8 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiara Temperoni Italy	6	170	128	127	99	85	9	491
Michael J. Rybak United States	10	181 1.1×	168 1.3×	161 1.3×	269 2.7×	65 0.8×	18	610
Amani Alnimr Saudi Arabia	12	101 0.6×	129 1.0×	29 0.2×	170 1.7×	39 0.5×	38	418
Giovanni Bonfiglio Italy	18	433 2.5×	205 1.6×	252 2.0×	78 0.8×	96 1.1×	41	807
Frieder Fuchs Germany	11	84 0.5×	102 0.8×	83 0.7×	439 4.4×	73 0.9×	31	659
Sergio García‐Fernández Spain	13	237 1.4×	160 1.3×	138 1.1×	173 1.7×	86 1.0×	34	523
Yiqi Fu China	14	457 2.7×	206 1.6×	112 0.9×	179 1.8×	112 1.3×	25	783
Rosalino Vázquez-López Mexico	12	190 1.1×	177 1.4×	35 0.3×	40 0.4×	44 0.5×	26	551
Nan Bai China	9	715 4.2×	190 1.5×	326 2.6×	94 0.9×	142 1.7×	20	935
Joseph Rutter United States	11	392 2.3×	157 1.2×	222 1.7×	102 1.0×	118 1.4×	18	642
Zohreh Aminzadeh Iran	9	274 1.6×	70 0.5×	47 0.4×	76 0.8×	100 1.2×	42	474

Countries citing papers authored by Chiara Temperoni

Since Specialization

Citations

This map shows the geographic impact of Chiara Temperoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Temperoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Temperoni more than expected).

Fields of papers citing papers by Chiara Temperoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Temperoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Temperoni. The network helps show where Chiara Temperoni may publish in the future.

Co-authorship network of co-authors of Chiara Temperoni

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Temperoni. A scholar is included among the top collaborators of Chiara Temperoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Temperoni. Chiara Temperoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Temperoni, Chiara, et al.. (2022). Secondary Infections in Critically Ill Patients with COVID-19: A Retrospective Study. Antibiotics. 11(11). 1598–1598. 5 indexed citations

Temperoni, Chiara, Stefania Grieco, Zeno Pasquini, et al.. (2021). Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infectious Diseases. 21(1). 134–134. 21 indexed citations

Pascale, Renato, Zeno Pasquini, Michele Bartoletti, et al.. (2021). Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study. JAC-Antimicrobial Resistance. 3(4). dlab174–dlab174. 66 indexed citations

Temperoni, Chiara, et al.. (2021). High Prevalence of Antibiotic Resistance among Opportunistic Pathogens Isolated from Patients with COVID-19 under Mechanical Ventilation: Results of a Single-Center Study. Antibiotics. 10(9). 1080–1080. 22 indexed citations

Pasquini, Zeno, Roberto Montalti, Chiara Temperoni, et al.. (2020). Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. Journal of Antimicrobial Chemotherapy. 75(11). 3359–3365. 31 indexed citations

Conti, Fabrizio, Fulvia Ceccarelli, Giancarlo Iaiani, et al.. (2016). Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus. Arthritis Research & Therapy. 18(1). 177–177. 38 indexed citations

Righi, Elda, Paola Della Siega, Maria Merelli, et al.. (2015). Comparison of clinical characteristics of tuberculosis between two age groups at an Italian Tertiary Hospital. Infection. 43(3). 361–366. 4 indexed citations

Falasca, Francesca, Chiara Temperoni, Laura Mazzuti, et al.. (2014). Genetic analyses of HIV-1 pol sequences from Zimbabwean patients.. PubMed. 37(3). 377–81.

Bassetti, Matteo, et al.. (2013). New antibiotics for bad bugs: where are we?. Annals of Clinical Microbiology and Antimicrobials. 12(1). 22–22. 304 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact